Archive for February, 2013

Hyperion Wins NDA Approval for UCD Drug Developed With Support from…

PharmaDirections congratulates Hyperion Therapeutics on achieving an NDA approval for their RAVICTI™ (glycerol phenylbutyrate) Liquid for Treatment of Urea Cycle Disorders . PharmaDirections is proud…

(PRWeb February 27, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10442980.htm


Bed Bugs In 1,000’s Eat Woman Alive in Shocking Video, My Cleaning…

A woman from Frankfort Kentucky was hospitalized as bed bugs took over his house. My Cleaning Products suggested the use of a pesticide-exempt bed bug spray for the public to avoid the same incident.(PRWeb February 27, 2013)Read the full story at ht…


Priceless Samples Can Be Destroyed Due to Inefficient Incubator Doors:…

After years of manufacturing the popular 25 liter Incufridge, Revolutionary Science expands to a line of six Incufridge models. These incubator/refrigerators are wonderful for almost all microbiology…(PRWeb February 27, 2013)Read the full story a…


The quest for generic biotechnology pharmaceuticals in the USA

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
The quest for generic biotechnology pharmaceuticals in the USA
Go to paperABSTRACT: As patent protection expires on the first generation of biotechnology p…


Foundation for the NIH Announces Lurie Prize Recognizing Outstanding…

Ruslan M. Medzhitov, PhD to Receive Inaugural Prize for Ground-Breaking Work Exploring the Immune System(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/Lurie/Prize/prweb10413667.htm


The Week in Review: Top Stories in Outcomes Research, Market Access…

For Women Executives in Pharma, is the Glass Ceiling Made of Cement? Plus a New Web Series From HealthEconomics.Com Focusing on HE-Artists.(PRWeb February 26, 2013)Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/TopNews/prwe…